This petition was submitted during the 2015-2017 parliament
Petition Where a treatment exists, provide fair and fast access for rare disease patients
People with rare diseases wait on average over 2 years for potentially life-changing treatments. Less than half of treatments approved in the last 15 years are funded by NHS England vs. 93% in Germany and 81% in France. If a treatment exists, access should be the same as for more common conditions.
More details
The Department of Health, NICE and NHS England should work together with patient groups, clinical experts, and the Pharmaceutical Industry to establish a new and fair process for appraisal of rare disease medicines.
Data from the Report:
Equity and Access: Making the UK a Rare Disease Leader. (2017) Initiated and funded by Shire Pharmaceuticals and developed in collaboration with an external steering group
This petition, and the Equity and Access Report, were initiated and funded by Shire.
This petition closed early because of a General Election Find out more on the Petitions Committee website
7 signatures
Show on a map the geographical breakdown of signatures by constituency
10,000 signatures required to get a government response